The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Antidepressant drugs such as the serotonin (5-HT)/norepinephrine (NE) and dopamine (DA) reuptake inhibitors activate monoaminergic neurotransmission in various brain regions, such as the amygdala, the frontal cortex or the hippocampus. Although this property is well established, the post-synaptic mechanisms by which these pharmacological agents exert therapeutic activity in major depressive disorders (MDD) is not fully understood. Recent clinical and preclinical studies have indicated that the density and reactivity of glia and more particularly of astrocytes are reduced in MDD patients. These data along with the fact that astrocytes express monoaminergic transporters and receptors make these cells putative targets for antidepressant treatments. Accordingly, in vitro evidence has demonstrated that the application of various classes of antidepressant drugs on rodent primary astrocyte cultures elicits a wide spectrum of responses, from the rise in cytosolic calcium concentrations, as a marker of cellular activity, to the release of glucose metabolites, gliotransmitters and neurotrophic factors. Remarkably, antidepressant drugs also attenuate the release of inflammatory molecules from reactive astrocytes or microglia, suggesting that part of the beneficial effects in depressed patients or animal models of depression might result from the ability of antidepressants to regulate the synthesis and release of psychoactive substances acting on both pre- and post-synaptic neurons. Among the many long-term targets of antidepressant drugs, brainderived neurotrophic factor (BDNF) has been well studied because of the positive influence on adult hippocampal neurogenesis, synaptogenesis and the local serotonergic tone. This review will illustrate how the concept of the tripartite synapse, which is classically associated with different forms of plasticity involving glutamate, could be expanded to the monoaminergic systems to regulate antidepressant drug responses. The recent in vivo data supporting that hippocampal astrocytes act in concert with neurons to release BDNF under pharmacological conditions and thereby regulate different facets of anxiolytic-/antidepressant-like activities through neurogenesis-dependent and independent mechanisms will be emphasized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 2×
“These observations must be considered in the context of the “tripartite synapse” within the central nervous system (CNS) [20] in which astrocytes respond to intracellular calcium (Ca 2+ ) elevations during synaptic activity to regulate intrasynaptic monoamine levels under basal conditions or in response to antidepress…”
BackgroundInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“Although the acute administration of various SSRIs or the monoamine oxidase inhibitor tranylcypromine decreases the expression of BDNF in the HP [217-220], notably exon VI and V mRNA [219, 221, 222], the repeated administration (2-3 weeks) of these drugs produces the opposite effect [123, 219, 220, 222, 223] and rever…”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“The in vivo relevance of this process on the improvement of mood remains largely unexplored, although postmortem brain analyses and imaging studies in the late 90s reported glial dysfunction in the prefrontal and cingulate cortex of depressed patients [144-146].”
BackgroundVascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“The in vivo relevance of this process on the improvement of mood remains largely unexplored, although postmortem brain analyses and imaging studies in the late 90s reported glial dysfunction in the prefrontal and cingulate cortex of depressed patients [144-146].”
BackgroundHippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426 · cited 1×
“Together, these data strongly suggest that BDNF is predominantly synthesized by neurons [246], but reactive astrocytes could also produce this factor under particular conditions, such as in neurodegenerative diseases or after the exposure of cultured astrocytes to kainic acid [247, 248].”
BackgroundNibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Conner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 2×
“Accordingly, in situ hybridization studies in the HP of the adult rat brains reported that cells expressing the BDNF gene are found in pyramidal and granule neurons and in target cells receiving projections from BDNF-synthesizing neurons [101].”
BackgroundRequirement for BDNF in activity-dependent survival of cortical neurons
Ghosh, A., Carnahan, J., & Greenberg, M. E. (1994) · Science · doi:10.1126/science.7907431 · Cited by 989 · cited 1×
“Because BDNF expression, identified in rat cultured embryonic cortical neurons, can be stimulated by the activation of the cAMP system and voltage sensitive Ca 2+ channels [229], it is now accepted that mature hippocampal neurons represent the major source of BDNF.”
BackgroundLee, J., Duan, W., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01085.x · Cited by 975
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · cited 9×
“However, high concentrations of s100beta induce apoptosis, suggesting that the regulation of this neurotrophic factor by the 5-HT1A receptor could play a significant role in both the physiopathology of MDD and the antidepressant activity of SSRIs [74].”
BackgroundInfluentialHan, X., Chen, M., Wang, F., Windrem, M., Wang, S., Shanz, S., Xu, Q., Oberheim, N. A., Bekar, L., Betstadt, S., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.015 · Cited by 635
TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment
Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C.-H., Kernie, S. G., Bassel-Duby, R., & Parada, L. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.023 · Cited by 634 · cited 1×
“The role of BDNF and the related TrkB receptor in adult hippocampal neurogenesis has stimulated number of studies showing that this factor promotes the in vivo proliferation and differentiation of neuronal progenitor cells [240-243], accelerates the maturation of new neurons and facilitates neuronal survival [242-244].”
BackgroundCotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634 · cited 1×
“The in vivo relevance of this process on the improvement of mood remains largely unexplored, although postmortem brain analyses and imaging studies in the late 90s reported glial dysfunction in the prefrontal and cingulate cortex of depressed patients [144-146].”
BackgroundAstrocyte-derived ATP modulates depressive-like behaviors
Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., Fang, Y.-Y., Zhang, J., Li, S.-J., Xiong, W.-C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3162 · Cited by 615
Endotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604 · cited 1×
“Pro-inflammatory agents such as lipopolysaccharide (LPS) are known to promote depressive-like behaviors in rodents [167], likely through the recruitment of various events, including the activation of microglia, the synthesis of reactive oxygen species (ROS) and pro-inflammatory molecules in the brain [i.”
BackgroundAstrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603 · cited 2×
“A recent review by Rajkowska and Stockmeier (2013) [3] examined human post-mortem studies that demonstrated that MDD is associated with a decrease in the density of astrocytes in the AMY, FC or HP.”
BackgroundMiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Taliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · cited 2×
“Finally, antidepressant drugs have been shown to reverse glial cell loss and atrophy induced by chronic stress [4, 5, 19], suggesting a non-neuronal mechanism of action of these pharmacological agents.”
BackgroundDysregulation of the fibroblast growth factor system in major depression
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406788101 · Cited by 424 · cited 1×
“Moreover, treatment with antidepressants reduces this decreased expression of FGF-2 in MDD patients [211].”
BackgroundO’Donnell, J., Zeppenfeld, D., McConnell, E., Pena, S., & Nedergaard, M. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0818-x · Cited by 399
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E. (1998) · Nature Neuroscience · doi:10.1038/1557 · Cited by 374 · cited 1×
“The uptake2 transporters, such as the extraneuronal monoamine transporters (EMT), display distinct pharmacological profiles compared to the monoamine uptake1 transporters and were identified several years after the monoamine uptake1 [50, 51].”
BackgroundBernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372 · cited 1×
“Similar observations were made post-mortem in the cortical regions [165] and in the LC [166] of MDD patients in which microarray analyses showed a down-regulation of members of the glial glutamate/neutral amino acid transporter protein family.”
ResultCentral administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects
Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.007 · Cited by 348 · cited 1×
“Despite the fact that the precise source of BDNF remains somewhat equivocal, preclinical studies have clearly indicated that the intracerebroventricular and intra-hippocampal infusion of BDNF produces antidepressant-like activity in naive and stressed rodents [232-235], thereby demonstrating that the therapeutic activ…”
BackgroundBrown, A. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02421.x · Cited by 308 · cited 1×
“Given that astrocytes are the main cerebral source of glycogen and that the glycogenogenesis and glycogenolysis are key processes for the rapid production of energetic substrates [106-109], it is likely that the stimulation of the astrocytic 1- and 2-adrenoceptors plays a major role in the metabolism necessary for the…”
BackgroundGourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., & Taylor, J. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.016 · Cited by 287
Dias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274 · cited 1×
“Although the acute administration of various SSRIs or the monoamine oxidase inhibitor tranylcypromine decreases the expression of BDNF in the HP [217-220], notably exon VI and V mRNA [219, 221, 222], the repeated administration (2-3 weeks) of these drugs produces the opposite effect [123, 219, 220, 222, 223] and rever…”
BackgroundGap Junction Dysfunction in the Prefrontal Cortex Induces Depressive-Like Behaviors in Rats
Sun, J.-D., Liu, Y., Yuan, Y.-H., Li, J., & Chen, N.-H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.319 · Cited by 258 · cited 3×
“A first echo in a recent preclinical study in the rat chronic unpredictable stress model (UCMS) showed that structural and functional alterations of astrocytic gap junctions is restored by chronic SSRI fluoxetine or SNRI duloxetine treatment [28].”
BackgroundInfluentialde Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.054 · Cited by 249 · cited 1×
“Although the acute administration of various SSRIs or the monoamine oxidase inhibitor tranylcypromine decreases the expression of BDNF in the HP [217-220], notably exon VI and V mRNA [219, 221, 222], the repeated administration (2-3 weeks) of these drugs produces the opposite effect [123, 219, 220, 222, 223] and rever…”
BackgroundQuesseveur, G., David, D. J., Gaillard, M. C., Pla, P., Wu, M. V., Nguyen, H. T., Nicolas, V, Auregan, G., David, I., Dranovsky, A., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.30 · Cited by 235 · cited 2×
“It thus appears possible that under particular conditions, such as following the overexpression of astrocytic BDNF in adult mice [251], astrocytes could be a source of BDNF or can re-uptake BDNF as peripheral platelets do for 5-HT.”
BackgroundSelf-citationAnti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells
Liu, D., Wang, Z., Liu, S., Wang, F., Zhao, S., & Hao, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.033 · Cited by 221 · cited 1×
“This is confirmed by the observation that fluoxetine prevents LPS-induced inhibition of adult hippocampal neurogenesis in rats [173] by attenuating microglia activation [174].”
BackgroundMagistretti, P. J., Sorg, O., Yu, N., Martin, J.-L., & Pellerin, L. (1994) · Developmental Neuroscience · doi:10.1159/000111349 · Cited by 205 · cited 1×
“Given that astrocytes are the main cerebral source of glycogen and that the glycogenogenesis and glycogenolysis are key processes for the rapid production of energetic substrates [106-109], it is likely that the stimulation of the astrocytic 1- and 2-adrenoceptors plays a major role in the metabolism necessary for the…”
BackgroundInhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants
Hwang, J., Zheng, L. T., Ock, J., Lee, M. G., Kim, S.-H., Lee, H.-W., Lee, W.-H., Park, H.-C., & Suk, K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.045 · Cited by 181 · cited 1×
“Remarkably, the acute administration of tricyclics and of paroxetine, fluoxetine or desipramine prevented the release of inflammatory mediators in the rat cortex, in primary cultured forebrain microglia and in astrocytes from newborn mice [171, 172] suggesting that antidepressant drug activity could rely on action on…”
BackgroundHippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder
Gaughran, F., Payne, J., Sedgwick, P. M., Cotter, D., & Berry, M. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.04.008 · Cited by 178
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176 · cited 1×
“Consistent with the latter study, in vitro data showed that different classes of antidepressant drugs, including TCAs and SSRIs, modulate GDNF expression in cultured cortical rat astrocytes and in C6 glioma cells [199-201].”
ResultAntidepressant Effects of Fibroblast Growth Factor-2 in Behavioral and Cellular Models of Depression
Elsayed, M., Banasr, M., Duric, V., Fournier, N. M., Licznerski, P., & Duman, R. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.003 · Cited by 169 · cited 1×
“Indeed, cortical FGF-2/FGFR signaling is necessary for mediating the antidepressant-like effects of imipramine and fluoxetine in the chronic unpredictable stress model of depression in rats [215].”
BackgroundAntidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling
Hines, D. J., Schmitt, L. I., Hines, R. M., Moss, S. J., & Haydon, P. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.136 · Cited by 160 · cited 1×
“In addition to these data, it has been reported that 12 hours of sleep deprivation induces an increase in the hippocampal extracellular adenosine levels and in the adenosine receptor A1 signaling in the mouse brain, whereas the central administration of a potent and selective A1 receptor agonist mimics the antidepress…”
BackgroundEngineered lentiviral vector targeting astrocytes In vivo
Colin, A., Faideau, M., Dufour, N., Auregan, G., Hassig, R., Andrieu, T., Brouillet, E., Hantraye, P., Bonvento, G., & Déglon, N. (2009) · Glia · doi:10.1002/glia.20795 · Cited by 158
O'Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800967x · Cited by 146
Greene, J., Banasr, M., Lee, B., Warner-Schmidt, J., & Duman, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.68 · Cited by 143 · cited 1×
“There is also evidence that VEGF signaling is required for the effects of fluoxetine in different behavioral paradigms and that the chronic administration of this SSRI increases the expression of VEGF in neurons and endothelial cells of the HP [208].”
BackgroundAoki, C. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.3.269 · Cited by 138 · cited 1×
“In vitro and in situ experiments have demonstrated that both the 1- and 2-adrenoceptors are expressed on astrocytes from various brain regions [92-96].”
BackgroundAntidepressant-like effects of intracerebroventricular FGF2 in rats
Turner, C. A., Gula, E. L., Taylor, L. P., Watson, S. J., & Akil, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.088 · Cited by 125 · cited 2×
“Animal studies have also shown that the expression of FGF-2 is reduced notably in the HP of rats subjected to the social defeat model of depression [212], whereas antidepressant drugs produced the opposite effects in the HP and in the FC [213, 214].”
BackgroundResultRantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124 · cited 1×
“Accordingly, as the high affinity receptor of BDNF, TrkB is autophosphorylated in response to the chronic administration of various classes of antidepressant drugs in the mouse HP and cingulate cortex [236, 237], whereas transgenic mice with the non-functional truncated TrkB are less sensitive to these treatments [238…”
BackgroundFunctional expression of the norepinephrine transporter in cultured rat astrocytes
Inazu, M., Takeda, H., & Matsumiya, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01514.x · Cited by 86 · cited 3×
“Although the Na + -dependent or independent uptake of NE by astrocytes has led to heterogeneous results [32, 40, 42, 43], it is now well accepted that selective and non-selective NE reuptake inhibitors, such as nisoxetine, milnacipran or desipramine, inhibit the in vitro Na + -dependent NE uptake from cultured rat ast…”
BackgroundResultImipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M., & Nakamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12039fp · Cited by 70 · cited 1×
“imipramine, amitriptyline and TRIs upregulate BDNF in primary cultures of astrocytes [17, 138, 231], suggest that glial cells represent a permissive microenvironment for the production of new neurons and neuronal integration into existing functional networks in the dentate gyrus of the HP.”
BackgroundZhang, S., Li, B., Lovatt, D., Xu, J., Song, D., Goldman, S. A., Nedergaard, M., Hertz, L., & Peng, L. (2010) · Neuron Glia Biology · doi:10.1017/s1740925x10000141 · Cited by 69 · cited 1×
“The presence of the 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes in primary astrocyte cultures from various brain regions, including the HP [12, 75, 76], and also from in situ analyses [77] has been repeatedly documented.”
BackgroundSatoh, Y., Kobayashi, Y., Takeuchi, A., Pagès, G., Pouysségur, J., & Kazama, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2243-10.2011 · Cited by 66 · cited 1×
“Because a downregulation of ERK1/2 has been associated with an impairment of the adult hippocampal neurogenesis during brain development [82], it is possible that such an effect in the adulthood could also dampen this process in the adult HP.”
BackgroundLi, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1631-3 · Cited by 52 · cited 2×
“As expected, the stimulation of the 5-HT2 receptors by 5-HT and the SSRIs fluoxetine or citalopram in rodent primary cultures of cortical astrocytes increases [Ca 2+ ]i and protein kinase C (PKC) activity, which is responsible for the extracellular signal-regulated kinase1/2 (ERK1/2) activation [78, 79] (Fig.”
Background
Cited by
Liu, Y., Zhao, J., & Guo, W. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02201 · Cited by 261
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Wei, C.-L., Wang, S., Yen, J.-T., Cheng, Y.-F., Liao, C.-L., Hsu, C.-C., Wu, C.-C., & Tsai, Y.-C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.01.025 · Cited by 150
“Long-term treatment with SSRIs also desensitizes the presynaptic autoreceptors and enhances 5-HT neurotransmission (Blier, 2001; Quesseveur et al., 2013).”
Zemdegs, J., Martin, H., Pintana, H., Bullich, S., Manta, S., Marqués, M. A., Moro, C., Layé, S., Ducrocq, F., Chattipakorn, N., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2904-18.2019 · Cited by 151
Self-citation
Metadata
- Authors
- Quesseveur, G., Gardier, A., & Guiard, B.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-09-01
- Volume
- 14
- Issue
- 11
- Pages
- 1277-1294
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2116758613
- Cited by
- 51
- References
- 60
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.